课题基金 / 基金详情

Development of the targetable and fusogenic polyethyleneglycol liposomes for gene delivery

Development of the targetable and fusogenic polyethyleneglycol liposomes for gene delivery
用于基因递送的可靶向融合聚乙二醇脂质体的开发
批准号:
08672568
负责人:
MARUYAMA Kazuo
金额:
$1.41万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1996
资助国家:
日本
项目状态:
已结题
起止时间:
1996 至 1998

项目摘要

项目成果

MARUYAMA Kazuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
For the purpose of intracellular targeting carrier by systemic administration, PEG-liposomes conjugating transferrin (TF) at the distal ends of PEG chain were newly prepared. Biodistribution of TF-PEG liposome was examined in the colon 26 bearing mice. TF-PEG liposome were prolonged in the circulation and highly accumulated into the tumor tissue. After extravasation, TF-PEG liposome retains the specific binding ability to tumor cell surface. Uptake of TF-PEG liposome was examined by electron microscopy. TF-PEG liposome was localized at the cell surface, coated pits and endosome. These results show TF-PEG liposome was bound and internalized by endocytosis. Such liposomes should be useful for intracellular targeting carrier at the way of systemic administration.We prepared a new fusogenic liposomes modified with succinylated poly(glycidol)(sucPG), which is a polyethyleneglycol derivatives with carboxyl groups and alkyl groups. Furthermore, we prepared sucPG immunoliposomes, which were conjugated with TF, to gain the binding and endocytotic internalization to the tumor cells. SucPG liposomes (eggPC : sucPG=4 : 1 w/w) showed fusion ability under acidic condition such as pH4.O.From the fluorescent microscopic observation, it was shown that TF-sucPG irnmunoliposomes bound to colon26 tumor cells and induced endocytosis. These results suggested the occurrence of fusion between sucPG immunoliposomes and endosome membrane. TF-sucPG immunoliposomes have targeting and fusion ability to the Colon26 tumor cells. Thus we have succeeded to develop the targetable and fusogenic liposomes. TF-sucPG immunoliposome could be useful for as a vector in gene therapy.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
棚橋宏行: "トランスフェリン修飾PEG-リポソームの腫瘍細胞への結合性 : 細胞内ターゲティングを目指して" Progress in Drug Delivery system. 6. 23-32 (1997)
Hiroyuki Tanahashi:“转铁蛋白修饰的 PEG 脂质体与肿瘤细胞的结合:朝向细胞内靶向”药物递送系统的进展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuo Maruyama PhD: "Long-circulating immunoliposome targeting in animal models" J.Liposome Res.7. 363-389 (1997)
Kazuo Maruyama 博士:“动物模型中的长循环免疫脂质体靶向”J.Liposome Res.7。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
片山国嗣: "PEG誘導体を用いたFusogenic proteo-Liposomeに関する基礎的研究" Progress in Drug Delivery system. 7. 29-38 (1998)
Kunitsugu Katayama:“使用PEG衍生物的融合蛋白脂质体的基础研究”药物递送系统的进展(1998)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
棚橋宏行: "トランスフェリン修飾PEG-リポソームの腫瘍細胞への結合性:細胞内ターゲティングを目指して" Progress in Drug Delivery system. 6. 23-32 (1997)
Hiroyuki Tanahashi:“转铁蛋白修饰的 PEG 脂质体与肿瘤细胞的结合:旨在细胞内靶向”药物递送系统的进展。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
6
    Development of new bubble with fluorous chemistry
    • 批准号:
      24650299
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2012
    • 负责人:
      MARUYAMA Kazuo
    • 依托单位:
    Ultrasound cancer therapy in next-generation with liposomal nanobubbles having both functions of diagnostics and therapeutics
    • 批准号:
      23300192
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2011
    • 负责人:
      MARUYAMA Kazuo
    • 依托单位:
    Therapeutic target for pulmonary hypertension based on coagulative and inflammatory cascade analysis
    • 批准号:
      21592003
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2009
    • 负责人:
      MARUYAMA Kazuo
    • 依托单位:
    Development of siRNA delivery system by the combination of bubble liposomes and ultrasound
    • 批准号:
      19300185
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $12.06万
    • 财政年份:
      2007
    • 负责人:
      MARUYAMA Kazuo
    • 依托单位:
    国内基金
    海外基金
    Microbubble-ZPDGFRβ/PFD/liposome通过靶向肝星状细胞改善肿瘤微环境抑制肝细胞癌复发转移的作用及机制研究
    • 批准号:
      82272000
    • 项目类别:
      面上项目
    • 资助金额:
      52万元
    • 批准年份:
      2022
    • 负责人:
      杨秀华
    • 依托单位:
    基于Gd-HPDO3A@Liposome-Ga-68的PET/MR用于肝肿瘤增强显像及酸碱微环境检测